A focused collection of 65 calculators, scores, and clinical references.
ACS And Gastrointestinal Bleeding PPI Indication Tool. Explanation And Clinical Context This tool is designed for patients with acute coronary syndrome who receive dual antiplatelet therapy oral anticoagulant therapy or both. The twenty twenty five ACC AHA ACS guideline states that in patients at high risk of gastrointestinal bleeding a proton pump inhibitor should be used together with dual antiplatelet therapy oral
Explanation and Clinical Context This tool is designed to support early identification of patients with suspected acute coronary syndromes who are likely to have acute myocardial infarction by combining high sensitivity cardiac troponin results with electrocardiographic findings and assay specific thresholds. The 2025 American Heart Association acute coronary syndromes guideline emphasizes that initial assessment sho
ACS Early Rule In Pathway Tool Explanation and Clinical Context This tool is designed to support early identification of patients with suspected acute coronary syndromes who are likely to have acute myocardial infarction by combining high sensitivity cardiac troponin results with electrocardiographic findings and assay specific thresholds. The 2025 American Heart Association acute coronary syndromes guideline emphasi
Explanation and Clinical Context This tool helps clinicians identify bedside clinical features that signal high risk acute coronary syndromes. It is designed for patients with suspected or confirmed acute coronary syndromes including non ST segment elevation presentations and ST segment elevation presentations. The focus is early recognition of unstable clinical states that may benefit from rapid invasive evaluation
Explanation and Clinical Context This tool provides a structured bedside approach to identify patients with acute coronary syndrome who may be suitable for early hospital discharge once initial management is complete. It is intended for use after the acute phase when the treating team is considering discharge and when electrocardiography biomarkers and imaging data are already available. The tool combines simple clin
Explanation and Clinical Context This calculator implements the TIMI risk score for ST elevation myocardial infarction to estimate thirty day mortality risk in patients with acute coronary syndrome who present with ST elevation. It uses simple clinical variables that are available at the bedside including age systolic blood pressure heart rate Killip class history of diabetes hypertension or angina anterior ST elevat
Explanation and Clinical Context This decision aid is designed to support bedside selection of an antithrombotic regimen for patients with acute coronary syndrome by integrating presentation type initial management strategy coronary stent status need for chronic oral anticoagulation history of ischemic stroke or transient ischemic attack and estimated bleeding risk into a structured medication suggestion. In the Amer
Explanation and Clinical Context This tool provides individualized pharmacotherapy recommendations for acute coronary syndrome based on AHA guideline twenty twenty five. Core therapy for all ACS patients includes rapid initiation of Aspirin P2Y12 inhibitor parenteral anticoagulation and high intensity statin therapy unless contraindicated. Dual antiplatelet therapy with Aspirin plus Ticagrelor or Prasugrel is preferr
Explanation and Clinical Context This calculator helps determine the optimal revascularization approach in acute coronary syndrome based on clinical urgency hemodynamic status ischemic burden and risk features recommended in the 2025 American Heart Association guideline. Revascularization strategies include Immediate reperfusion for ST elevation myocardial infarction or unstable electrical and hemodynamic profiles Ea
Explanation And Clinical Context This tool summarizes short term mortality and ischemic risk estimation for patients with acute coronary syndromes based on guideline supported risk scores. The 2025 American Heart Association acute coronary syndromes guideline highlights that risk for early death and major adverse cardiac events varies widely among patients and that structured risk assessment can support bedside decis
ACS Troponin Interpretation Aid Sex Specific Thresholds Explanation and Clinical Context This tool supports interpretation of high sensitivity cardiac troponin concentrations in patients with suspected acute coronary syndrome by relating the measured value to the appropriate sex specific ninety ninth percentile upper reference limit reported for the local assay. Current guidelines recommend high sensitivity troponin
ACUITY HORIZONS Score Explanation and Clinical Context The ACUITY HORIZONS risk score is a validated clinical tool that helps estimate the risk of major adverse cardiovascular events in patients presenting with acute coronary syndromes who undergo an early invasive strategy. This score incorporates age, renal function expressed through serum creatinine, hemodynamic status reflected by systolic blood pressure, and the
Explanation and Clinical Context Dual antiplatelet therapy combining aspirin and a P2Y12 receptor inhibitor is a cornerstone of treatment after acute coronary syndromes. The 2025 American Heart Association acute coronary syndromes guideline emphasizes that the intensity and duration of antiplatelet therapy should be individualized by balancing ischemic benefit against bleeding risk within a structured clinical decisi
CAD Consortium Score: Comprehensive Explanation and Clinical Context The CAD Consortium Score is a validated clinical tool developed to estimate the pre-test probability of obstructive coronary artery disease (>50% stenosis in at least one major epicardial vessel) in patients with stable chest pain. It replaces older prediction models such as the Diamond–Forrester model, which consistently overestimated risk in the m
Comprehensive Explanation: The Coronary Artery Disease – Reporting and Data System (CAD-RADS) is a standardized reporting framework for Coronary CT Angiography (CCTA) established by the Society of Cardiovascular Computed Tomography (SCCT) and the American College of Radiology (ACR). It categorizes the severity of coronary artery stenosis and provides consistent recommendations for patient management. Normal Values: -
About CADILLAC Risk Score: The CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Risk Score is a validated prognostic model developed to predict 30-day and 1-year mortality in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). It incorporates seven key post-PCI parameters: age >65 years, LVEF <40%, renal
History of diabetes No Yes Smoking No Yes Family history of myocardial infarction No Yes LDL cholesterol mg/dL HDL cholesterol mg/dL Triglycerides mg/dL Systolic blood pressure mmHg PROCAM Score: Explanation and clinical context The PROCAM score is a point based algorithm developed from the Prospective Cardiovascular Munster study. The model estimates the 10 year risk of acute coronary events using age, systolic bloo
CASS Score (Coronary Artery Surgery Study): Comprehensive Explanation and Clinical Context The CASS Score was developed from the Coronary Artery Surgery Study to quantify the anatomical extent and severity of coronary artery disease (CAD) based on angiographic findings. Each major coronary vessel (Left Main, LAD, LCx, RCA) is scored according to the percentage of luminal narrowing and its prognostic weight. A higher
Comprehensive Explanation: The CHA2DS2-VASc-ACS Score is an adaptation of the original CHA2DS2-VASc risk model—initially used for atrial fibrillation—to evaluate cardiovascular and cerebrovascular risk in patients with acute coronary syndrome (ACS) or post-myocardial infarction (MI). Higher scores indicate greater burden of systemic vascular disease and increased likelihood of recurrent events or mortality after MI.
Explanation and Clinical Context This tool helps clinicians judge when clopidogrel monotherapy is appropriate after acute coronary syndromes by integrating key constructs from the twenty twenty five American Heart Association guideline on acute coronary syndromes. The guideline emphasizes that dual antiplatelet therapy with aspirin and a P2Y12 inhibitor remains the default approach for at least one year in patients w
Conventional Troponin 0 to 3 to 6 Hour Diagnostic Algorithm Explanation and Clinical Context This tool is designed for patients with suspected acute coronary syndrome in whom a conventional cardiac troponin assay is used rather than a high sensitivity assay. According to the twenty twenty five acute coronary syndrome guideline, cardiac troponin is the preferred biomarker for detection of myocardial injury and acute m
CRUSADE Bleeding Score: Explanation and Clinical Context The CRUSADE Bleeding Score is a validated clinical tool developed to estimate the risk of in-hospital major bleeding among patients who present with non ST elevation acute coronary syndromes. The score was derived from a large multicenter registry and includes clinical variables that are available at the time of presentation. These factors include hematocrit, c
DAPT De Escalation Strategy Ticagrelor or Prasugrel to Clopidogrel Explanation and Clinical Context This calculator helps clinicians apply the two part concept of DAPT modulation in the twenty twenty five acute coronary syndrome guideline. The guideline confirms that ticagrelor and prasugrel are preferred over clopidogrel in most patients with ACS undergoing PCI because they reduce major adverse cardiovascular events
DAPT Score: Comprehensive Explanation and Clinical Context The Dual Antiplatelet Therapy (DAPT) Score is a validated clinical tool developed to help physicians decide whether to extend dual antiplatelet therapy beyond 12 months after coronary stent implantation. It balances ischemic benefit against bleeding risk based on nine clinical and procedural variables. A score of >2 suggests that prolonged DAPT may reduce the
Default dual antiplatelet therapy duration ≥ twelve months after acute coronary syndrome strategy tool explanation and clinical context Dual antiplatelet therapy which combines aspirin with an oral P two Y twelve inhibitor is a cornerstone of treatment after acute coronary syndrome because it lowers the risk of early and late thrombotic events including recurrent myocardial infarction and stent thrombosis across both
Delta Troponin Change Based Acute MI Algorithm This calculator helps evaluate likelihood of acute myocardial infarction based on serial high sensitivity troponin measurement using initial and repeat values combined with absolute and relative delta changes. Diagnosis is supported when at least one value exceeds the ninety ninth percentile reference limit with a rising or falling pattern that meets significant change t
About Gensini Score: The Gensini Score is a quantitative angiographic tool used to assess the severity of coronary artery disease (CAD). It considers both the degree of luminal narrowing and the importance of the lesion's location in the coronary tree. Each degree of stenosis (1–25% = 1 point; 26–50% = 2; 51–75% = 4; 76–90% = 8; 91–99% = 16; 100% = 32) is multiplied by a weighting factor based on the anatomic segment
GRACE 2.0 Risk Calculator for Acute Coronary Syndromes: Explanation and Clinical Context The GRACE risk model is a guideline supported prognostic tool for patients with acute coronary syndromes and is recommended in the 2025 American guideline on acute coronary syndromes to support risk assessment and to inform the choice and timing of an invasive strategy, especially in patients with non ST elevation acute coronary
GRACE Score: Comprehensive Explanation and Clinical Context The Global Registry of Acute Coronary Events (GRACE) Score is a validated risk assessment tool designed to predict mortality in patients with Acute Coronary Syndrome (ACS). It integrates eight clinical variables-age, heart rate, systolic blood pressure, serum creatinine, Killip class, ST-segment deviation, cardiac arrest on admission, and cardiac enzyme elev
HEART Score: Explanation and Clinical Context The HEART Score is a clinical risk stratification tool designed to evaluate patients presenting to the emergency department with chest pain. It focuses on identifying the risk of major adverse cardiac events within the next thirty days. The acronym HEART represents History, ECG, Age, Risk factors, and Troponin. Each component is scored from zero to two, producing a total
References Rao SV et al Twenty twenty five Acute Coronary Syndromes Guideline J Am Coll Cardiol Twenty twenty five Reichlin T et al One hour rule out and rule in of myocardial infarction using high sensitivity troponin T Arch Intern Med Twenty twelve Twerenbold R et al Prospective validation of the zero one hour algorithm J Am Coll Cardiol Twenty eighteen Chiang CH et al Safety of the ESC zero one hour algorithm Hear
Initial ACS ECG Triage Ten Minutes Action Tool Explanation and Clinical Context This tool is designed to support rapid triage of patients with suspected acute coronary syndrome at the point of first medical contact or emergency department arrival. The twenty twenty five ACC AHA guideline recommends that a twelve lead ECG be acquired and interpreted within ten minutes for patients with possible acute coronary syndrome
INTERHEART Risk Score: Comprehensive Explanation and Clinical Context The INTERHEART Risk Score is a globally validated tool developed from the INTERHEART study, which assessed over 30,000 participants across 52 countries. It identifies nine modifiable risk factors responsible for over 90% of myocardial infarction risk worldwide. These include smoking, hypertension, diabetes, abdominal obesity, poor diet, physical in
Killip Classification Severity Tool for Acute Coronary Syndrome: Explanation and Clinical Context The Killip classification is a bedside clinical scale that grades the severity of heart failure in the setting of acute myocardial infarction and acute coronary syndrome using simple physical examination findings including pulmonary rales third heart sound jugular venous pressure acute pulmonary edema and cardiogenic sho
Long Term Dual Antiplatelet Therapy Extension Consideration Tool Explanation and Clinical Context This tool provides a structured approach to consider extension of dual antiplatelet therapy beyond the first year after an acute coronary syndrome. It is intended for patients who have completed at least several months of dual antiplatelet therapy with aspirin and a P2Y12 inhibitor and who are now being evaluated for con
Explanation and Clinical Context This decision tool is designed for patients with non ST segment elevation acute coronary syndromes who are potential candidates for coronary revascularization. The tool combines the GRACE risk score with simple clinical variables to help clinicians decide between a routine invasive strategy and a selective invasive strategy, and to estimate the appropriate timing of coronary angiograp
Explanation and Clinical Context This tool is intended for adults who present with non ST elevation acute coronary syndrome and in whom type 1 myocardial infarction due to plaque rupture is suspected. It summarizes key predictors that are mentioned in the twenty twenty five acute coronary syndrome guideline to estimate the likely benefit from an early invasive strategy and to suggest a practical time window for coron
PAMI Risk Score: Comprehensive Explanation and Clinical Context The PAMI (Primary Angioplasty in Myocardial Infarction) Risk Score is a clinical tool developed to predict 30-day mortality in patients with ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI). It uses seven readily available clinical variables: age, comorbidities, heart rate, systolic blood pressure,
PARIS Bleeding Risk Score: Comprehensive Explanation and Clinical Context The PARIS Bleeding Risk Score is a validated clinical tool developed to estimate the risk of major bleeding in patients undergoing dual antiplatelet therapy after percutaneous coronary intervention. It incorporates simple bedside variables that reflect age related vulnerability, hemodynamic reserve, underlying comorbidities, and previous bleedi
Comprehensive Explanation and Clinical Context: The PARIS Thrombosis Risk Score (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients) is a clinical tool designed to predict the likelihood of stent thrombosis and major adverse cardiac events (MACE) among patients receiving dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI). Variables and Scoring: The score is derived fr
Clinical Context This tool supports bedside discussion of dual antiplatelet therapy after acute coronary syndrome by explicitly contrasting ischemic protection with bleeding hazard in the first year after the event. Guideline recommendations describe dual antiplatelet therapy with aspirin plus an oral P2Y12 inhibitor for at least twelve months as the default in patients without high bleeding risk while also emphasizi
Post acute coronary syndrome secondary prevention optimisation tool explanation and clinical context This tool is designed to support a structured review of long term therapy in patients who have recently experienced an acute coronary syndrome event. The twenty twenty five acute coronary syndrome guideline emphasises that risk of recurrent events remains elevated for months to years after the index presentation and t
Explanation and Clinical Context This score is designed for patients resuscitated from cardiac arrest presenting with ST elevation myocardial infarction who achieve return of spontaneous circulation. Early prognostic insight provides clinical value in guiding revascularization timing and post arrest intensive care strategy including ventilation sedation temperature target management and hemodynamic support. Factors i
Explanation and Clinical Context This tool is designed as a structured aid for clinicians who individualize antiplatelet strategy after percutaneous coronary intervention in the setting of acute coronary syndromes. Current professional guidelines emphasize that duration and intensity of antiplatelet therapy after PCI are determined by a balance between ischemic risk related to the coronary event and stent characteris
clinical explanation Posterior myocardial infarction represents involvement of the basal inferolateral left ventricular wall usually supplied by the circumflex artery. Standard twelve lead ECG often underdetects this pattern because posterior injury current produces reciprocal ST depression in V1 V3 instead of direct elevation. For this reason posterior leads V7 V9 are recommended when posterior infarction is suspect
Explanation and Clinical Context The PURSUIT risk score was derived from a large international randomized trial of patients with unstable angina and non ST elevation myocardial infarction who received standard care with or without the glycoprotein two b three a inhibitor eptifibatide. It combines five bedside clinical features age sex worst Canadian Cardiovascular Society angina class in the preceding six weeks clini
References American Heart Association. Twenty twenty five Acute Coronary Syndromes Guideline. Journal of the American College of Cardiology. Twenty twenty five Zellweger M J et al. Right ventricular involvement in inferior myocardial infarction. European Heart Journal. Two thousand four Goldstein J A. Pathophysiology and management of right ventricular infarction. Current Cardiology Reports. Two thousand seven
Explanation and Clinical Context This tool is intended for patients who have experienced out of hospital or in hospital cardiac arrest have achieved return of spontaneous circulation and subsequently are found to have an electrocardiographic pattern consistent with ST segment elevation myocardial infarction. The twenty twenty five American acute coronary syndromes guideline emphasizes that patients with return of spo
Explanation and Clinical Context This tool translates guidance from the twenty twenty five American College of Cardiology and American Heart Association guideline for acute coronary syndromes into a structured approach to repeat twelve lead electrocardiograms in patients with suspected or confirmed acute coronary syndrome. The guideline recommends acquisition and interpretation of an ECG within ten minutes of first m
Serial Troponin Trajectory Interpretation. Comprehensive Explanation and Clinical Context Serial measurement of high sensitivity cardiac troponin plays a pivotal role in the diagnosis of acute coronary syndrome. The 2025 AHA ACS guideline emphasizes rapid rule in and rule out assessment using baseline and 1 to 2 hour repeat hs troponin values combined with clinical history and ECG findings. Serial trajectory interpre
Explanation and Clinical Context This tool is designed for patients with acute coronary syndromes who have undergone percutaneous coronary intervention with contemporary drug eluting stents and are treated with dual antiplatelet therapy that combines aspirin and an oral P2Y12 inhibitor. The 2025 acute coronary syndromes guideline identifies a default strategy of about 12 months of dual antiplatelet therapy in patient
Single Antiplatelet Therapy Transition for High Bleeding Risk: Explanation and Clinical Context Transition from dual antiplatelet therapy to single antiplatelet therapy is supported in the management of high bleeding risk patients after percutaneous coronary intervention according to the AHA ACS Guideline 2025. For patients with elevated bleeding tendency a shorter DAPT duration is reasonable and may safely reduce he
Single Sample hs Troponin Evaluation ≥3 Hours Symptom: Explanation and Clinical Context High sensitivity cardiac troponin is the preferred biomarker for evaluating suspected acute coronary syndrome. AHA 2025 guideline states that hs Troponin allows earlier rule out or rule in of myocardial infarction. When evaluating a patient who presents at least three hours from symptom onset a single hs Troponin below the assay s
Explanation and Clinical Context This tool supports bedside decisions about how urgent reperfusion should be in patients with suspected ST segment elevation myocardial infarction and which reperfusion strategy is most appropriate in a given clinical setting. It uses simple inputs that mirror key elements of the 2025 guideline for acute coronary syndromes including the type of hospital time from symptom onset to first
Stress Test versus Coronary Computed Tomography Before Discharge Pathway Tool Explanation and Clinical Context In contemporary management of acute coronary syndromes the two thousand twenty five guideline from the American College of Cardiology and the American Heart Association notes that selected patients can safely undergo either noninvasive stress testing or coronary computed tomography angiography before hospita
About SYNTAX II Score: The SYNTAX II Score combines anatomical and clinical variables to estimate 4-year mortality and guide revascularization strategy between PCI and CABG in patients with complex coronary artery disease. It improves upon the original SYNTAX I Score by incorporating key clinical parameters including age, sex, LVEF, renal function, COPD, PAD, and clinical presentation. Clinical Interpretation: A lowe
SYNTAX Score: Explanation and Clinical Context The SYNTAX Score is an angiographic tool to quantify the anatomical complexity of coronary artery disease by scoring each lesion with diameter stenosis of at least 50 percent in vessels of at least 1.5 millimeters. Each lesion is assigned a numeric value that reflects the myocardial territory at risk by a segment weight. The segment weight is multiplied by an occlusion m
Explanation and Clinical Context The GRACE risk model is widely used for early mortality and adverse event risk estimation in non ST elevation ACS and is endorsed within the AHA ACS Guideline 2025 as a validated tool for guiding treatment intensity including invasive strategy timing pharmacotherapy duration and monitoring needs. Variables in this calculator represent core elements of GRACE which include age heart rat
Table Based TIMI NSTEMI STEMI Tool Explanation and Clinical Context This tool is based on the TIMI risk model integrated in the twenty twenty five acute coronary syndrome guideline as one of validated approaches for rapid prognosis stratification in unstable angina and NSTEMI STEMI continuum. It assigns one point to seven clinical variables including older age sixty five or more, presence of three or more traditional
Explanation and Clinical Context This clinical tool assists in bedside decision making for long term P2Y12 therapy in patients treated for acute coronary syndrome with percutaneous coronary intervention. The twenty twenty five acute coronary syndrome guideline describes that ticagrelor based dual antiplatelet therapy for up to twelve months is the standard after PCI unless bleeding risk becomes unacceptable. Recurren
References American Heart Association Twenty twenty five Guideline for Management of Acute Coronary Syndromes JACC Twenty twenty five Mehran R et al Ticagrelor with or without aspirin after PCI NEJM Twenty nineteen Kim B K et al Ticagrelor monotherapy versus ticagrelor plus aspirin in ACS after PCI TICO trial JACC Twenty twenty
Explanation - TIMI Risk Score for STEMI: Comprehensive Overview The TIMI Risk Score for STEMI (Thrombolysis In Myocardial Infarction) is a clinical tool used to estimate short-term (30-day) mortality in patients with ST-elevation myocardial infarction. It was developed by Morrow et al. (Circulation, 2000) using data from the InTIME-II trial, aiming to simplify bedside risk assessment at patient presentation. Each cli
TIMI Risk Score for UA/NSTEMI: Comprehensive Explanation and Clinical Context The TIMI (Thrombolysis In Myocardial Infarction) Risk Score is a validated tool used to predict the likelihood of adverse cardiovascular outcomes (death, myocardial infarction, or urgent revascularization) within 14 days in patients with Unstable Angina (UA) or Non ST-Elevation Myocardial Infarction (NSTEMI). It consists of seven clinical p
Explanation and Clinical Context This tool is designed for patients with non ST segment elevation acute coronary syndrome and helps clinicians identify situations in which an immediate invasive strategy with urgent coronary angiography is appropriate. The 2025 American guideline on acute coronary syndromes states that patients with NSTE ACS who have refractory angina or hemodynamic or electrical instability should un
Zwolle Risk Score (Post-PCI): Comprehensive Explanation and Clinical Context The Zwolle Risk Score was developed to predict 30-day mortality and assess early discharge eligibility for STEMI patients after primary PCI. It incorporates six clinical and angiographic variables easily obtainable post-procedure: age, Killip class, TIMI flow, three-vessel disease, anterior infarction, and ischemic time. Clinical Significanc